While medical advances have significantly increased our ability to give life to pre-term infants, more cognitive disabilities and disadvantages are present when these children reach school age. Is the deficit is due to early separation from the mother, or possibly our post-delivery treatments? Dr. Anna Penn, assistant professor of pediatrics at Stanford University School of Medicine, and a neonatologist at Packard Children's Hospital, talks with host Dr. Bill Rutenberg about her current research in this area. Dr. Penn specifically addresses how hormone levels impact the brain development of preemies.
Hormones & Brain Development in Preemies
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
While medical advances have significantly increased our ability to give life to pre-term infants, more cognitive disabilities and disadvantages are present when these children reach school age. Is the deficit is due to early separation from the mother, or possibly our post-delivery treatments? Dr. Anna Penn, assistant professor of pediatrics at Stanford University School of Medicine, and a neonatologist at Packard Children's Hospital, talks with host Dr. Bill Rutenberg about her current research in this area. Dr. Penn specifically addresses how hormone levels impact the brain development of preemies.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credits
<p>Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
<p>Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial </p>
Cardiology
FINE-HEART Pooled Analysis
<p><span data-teams="true">FINE-HEART Pooled Analysis</span></p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?